PAVmed, Inc. (PAVM) Total Debt to Capital

PAVmed Inc. - graphic logo of issuer PAVM

PAVmed Inc. (PAVM) operates as a diversified medtech holding company, competing with niche tech giants across various segments. The company's financial position is complicated by debts within its cancer diagnostics divisions and uncertainty regarding insurance reimbursements. The business relies on outsourcing sensor production while retaining intellectual property rights. This price chart reflects the total debt-to-equity ratio, which currently stands at 0.52.

PAVmed, Inc. (PAVM): Total Debt to Capital Coefficient from 07/04/2022 to 10/29/2026

Metric breakdowns and analytics for PAVmed (PAVM)

- price and consensus price forecast:
Price Chart PAVmed, Inc.|PAVM - Consensus Target
- market capitalization details:
Market Capitalization PAVmed|PAVM - Company Buyout Price
- book capitalization indicators:
Net Assets per Single Share PAVmed|PAVM - Book Valuation of Business|Market Capitalization to Book Value Ratio pavmed.com|PAVM - Cumulative Company Assets
- debt and liquidity data:
Total Debt to Capital PAVmed Inc.|PAVM - Long-Term Liabilities to Capital|Short-Term Debt to Equity PAVmed, Inc.|PAVM - Company Debts|Debt to Book Capitalization Ratio PAVmed|PAVM - Company Long-Term Debt|Company Short-Term Debts PAVmed|Quick Liquidity pavmed.com
- net income and valuation ratios data:
PAVM - Company Profit
Summary company analysis:PAVM, PAVmed Inc.
Finished products of PAVmed, Inc.

This ratio measures the degree of business dependence on borrowed funds by comparing total liabilities to equity to assess financial stability and bankruptcy risks. By analyzing changes in the total debt-to-equity ratio, an investor can evaluate how effectively PAVmed Inc. finances the development of the EsoGuard diagnostic ecosystem and expansion into the Medicare segment without incurring an excessive debt load.

Key competitors

Debt to Equity Stryker|Total Debt to Equity Ratio Medtronic Inc. (MDT)|Total Debt to Capital PHG|Total Debt to Capital Coefficient Smith+Nephew|Debt to Equity Hologic, Inc. HOLX|Total Debt to Capital Coefficient carlisle.com (CSL)|Integer - Total Debt to Capital|LivaNova plc (LIVN) - Total Debt to Equity Ratio|AHCO: Total Debt to Capital|Debt to Capital SS Innovations International, Inc. (SSII)|Debt to Equity Avanos Medical, Inc.|Debt to Equity SI|Debt to Equity Viemed (VMD)|Debt to Equity INGN (inogen.com)|Total Debt to Capital OWLT (Owlet)|Total Debt to Capital Quipt QIPT|POCI - Debt to Equity|TIVC (tivichealth.com) - Debt to Equity Ratio|MOVE: Total Debt to Capital|Debt to Capital Holdco Nuvo Group (NUVO)